Pharmaxis improves annual result

Company News

Pharmaxis Limited (ASX:PXS) has seen an improvement in its annual result because of reduced operating expenses.

The loss is 1 per cent smaller than the previous year. The net loss was $45.7 million, down from $46.3 million the year before. Revenue fell 17 per cent.

The pharmacist, which develops treatments for respiratory conditions will pay no final dividend.


Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?